Profile
Investor Profil
Language
FR
Altaroc
Companies
Verdiva Bio
Verdiva Bio
manager
General Atlantic
sector
Healthcare
regional split
Europe
vintage
Odyssey 2021
status
Portfolio
category
Innovative

Verdiva Bio

Co-invested company
A company specializing in the treatment of obesity
Founded in 2024, Verdiva Bio is a clinical-stage biopharmaceutical company specializing in the development of innovative therapies for obesity and cardiometabolic disorders.
Visit the website

Key figures for Verdiva Bio

2024
creation date
+600
employees
3
products in development
2
country
Data as at
13/5/25
*Source: Public data from companies’ websites and social media accounts. For more up-to-date information, we invite our investors to view the report made available on their space.

The Altaroc Odyssey 2021 is no longer available.

About Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing next-generation treatments for obesity and cardio-metabolic disorders.

Its portfolio includes oral and injectable therapies, currently in phase 2 clinical development. This treatment showed promising efficacy in a Phase 1 trial in Australia.

‍

Company news
Button Text

In the same sector as Verdiva Bio

Discover all the companies
Company
ObjectiveHealth
Founded in 2018 in the USA, ObjectiveHealth designs software solutions to accelerate the identification and recruitment of patients taking part in clinical trials.
North America
Healthcare
Vitruvian
#
Odyssey 2024
Positive impact
Company
Global Data
GlobalData is a leading provider of data, analysis and information on the world's major industries.
Europe
Healthcare
Inflexion
#
Odyssey 2023
Unicorn
Company
RoC
RoC is an iconic French cosmetics brand specialising in anti-ageing skincare.
Europe
Healthcare
Bridgepoint
#
Odyssey 2022
A must
Company
HealthDrive
HealthDrive practitioners provide a full range of clinical services in long-term care facilities.
North America
Healthcare
Cressey & Company
#
Odyssey 2022
Positive impact
Company
Vivacy
Vivacy is a fast-growing leader in the field of hyaluronic acid-based injectable dermal fillers. Its products, exported to over 85 countries, are used in non-invasive medical aesthetic procedures to visibly smooth wrinkles or add volume.
Europe
Healthcare
Bridgepoint
#
Odyssey 2022
A must
Company
Palex
Palex Medical is a Spanish company distributing equipment and solutions for hospitals for over 40 medical specialities
Europe
Healthcare
Apax
#
Odyssey 2022
Innovative
Company
Equality Health
Equality Health is a US company dedicated to improving access to healthcare and reducing disparities in underserved areas.
North America
Healthcare
General Atlantic
#
Odyssey 2021
Positive impact
Company
Cleerly
Founded in 2017, Cleerly is an American medical technology company specializing in heart attack prevention using artificial intelligence-based analytics.
North America
Healthcare
Insight Partners
#
Odyssey 2025
Innovative
Company
Azara healthcare
Founded in 2011, Azara Healthcare is a leading US company in healthcare data analytics solutions.
North America
Healthcare
Insight Partners
#
Odyssey 2025
Positive impact
Company videos
No items found.
Learn more about our exclusive services
Become a Partner
General Atlantic
General Atlantic
General Atlantic
Odyssey 2021
Odyssey 2021
Odyssey 2021
Odyssey 2021
Portfolio
Dream Games
Portfolio
Kline Hill Partners
Portfolio
Verdiva Bio
Portfolio
Specter Ops
Portfolio
Onebrief
Portfolio
Flightkeys
Portfolio
Finout
Portfolio
Cosmo Tech
Portfolio
Cleerly
Portfolio
Azara healthcare
Portfolio
Grupo GSH
Portfolio
Filevine
Portfolio
Eventus Wholehealth
Portfolio
Klook
Portfolio
Superstruct
Portfolio
Therakos
Portfolio
Eckoh
Portfolio
UnameIT
Portfolio
TMA
Portfolio
Procilon Group
Portfolio
Facts Global Energy
Portfolio
Craigs Investment Partners
Portfolio
CompuGroup Medical
Portfolio
Comarch
Portfolio
Brycer
Portfolio
Baker Tilly
Portfolio
Esker
Portfolio
Meristem
Portfolio
Ascendia
Portfolio
Ecore
Portfolio
Seaport Therapeutics
Portfolio
HighLevel
Portfolio
Insider
Portfolio
Hargreaves Lansdown
Portfolio
Writer
Portfolio
Regnology
Portfolio
SAMY Alliance
Portfolio
Vuori
Portfolio
Monbake
Portfolio
AMCS
Portfolio
KEV Group
Portfolio
Qlik
Portfolio
Eyewa
Portfolio
Runway AI
Portfolio
Salute Mission Critical
Portfolio
Datassential
Portfolio
One Inc
Portfolio
Xitres
Portfolio
ThoughtWorks
Portfolio
Anaqua
Portfolio
Quote
Portfolio
Empyrean Solutions
Portfolio
Max Matthiessen
Portfolio
Vi Labs
Portfolio
Sysdyne Technologies
Portfolio
Smith & Williamson
Portfolio
Septeo
Portfolio
Schuberg Philis
Portfolio
Pictor Labs
Portfolio
Ivalua
Portfolio
Watermark
Portfolio
Anaconda
Portfolio
Solifi
Portfolio
LeagueApps
Portfolio
SDCL
Portfolio
DCar
Portfolio
Odevo
Portfolio
VisiQuate
Portfolio
Fulgard
Portfolio
Epicor
Portfolio
Kyriba
Portfolio
RiskConcile
Portfolio
Springbrook
Portfolio
Alpha FMC
Portfolio
Flo Health
Portfolio
CTAIMA
Portfolio
Ncontracts
Portfolio
WhiteVision
Portfolio
Heartbeat
Portfolio
Söderberg & Partners
Portfolio
Veriforce
Portfolio
Altus Fire & Life Safety
Portfolio
Aduro Advisors
Portfolio
Flowbird Group
Portfolio
ObjectiveHealth
Portfolio
OAG
Portfolio
Aspia
Portfolio
Redarbor
Portfolio
Partners Capital
Portfolio
Athletic Brewing
Portfolio
Induce
Portfolio
n2y
Portfolio
Expana (ex-Mintec)
Portfolio
JTL
Portfolio
EDH
Portfolio
CINC Systems
Portfolio
A2MAC1
Portfolio
Cube
Portfolio
GTreasury
Portfolio
Howden
Newsletter
In our monthly newsletter, you can find out about new divestments and acquisitions made by the Altaroc Vintages, as well as exclusive analyses of the leading figures shaping Private Equity.
Subscribe
Contacts
We’re always happy to chat.
Contact us
Our Private Equity offerings
Odyssey 2025
Odyssey 2024
Odyssey 2023
Odyssey 2022
Odyssey 2021
Discovery FCPR
Altalife 2023
understanding Private Equity
What is Private Equity?Webinars & eventsAltaroc videosWhite PapersPrivate Equity GlossaryPrivate Equity FAQs
Altaroc
ManifestoHistoryGeneral PartnerThe TeamOur ESG commitmentsRoadmap
For professionals
Become a PartnerMy SpaceAltaroc in the pressNews from our VintagesOur managersPortfolio of companies
Altaroc 2021 -2025
Your cookie preferencesGTCTerms of useCookie policyPrivacy policyDocumentary libraryPress
Important information
Information on investment performance is given solely for illustration purposes. Past performance is not a reliable guide to future results. An investment in Private Equity involves a high degree of risk. Potential investors must have the financial capacity and willingness to bear the risks associated with investing in the Funds (including the potential total loss of their capital), as well as – in the case of the Altaroc ranges – the lack of liquidity. Find out more here.
8 seconds to show you the relevant information on our website
OK
click Enter
Please select your country of tax residence
France
France
United Kingdom
Italy
Belgium
Netherlands
Luxembourg
Switzerland
Other
Please select your preferred language
French
English
German
Italian
Your investor profile
I am an informed or professional investor
I am a non-professional investor
General Terms and Conditions

Dieser Bereich der Website von Altaroc Partners richtet sich ausschließlich an professionelle oder sachkundige Anleger.

Mit dem Zugriff bestätigen Sie, dass Sie ein professioneller Anleger im Sinne der Richtlinie 2014/65/EU und des Artikels L.533-16 des französischen Währungs- und Finanzgesetzbuchs sind, der über die erforderliche Erfahrung, das Wissen und die Fachkenntnisse verfügt, um eigenständige Anlageentscheidungen zu treffen und die damit verbundenen Risiken angemessen einzuschätzen; ein sachkundiger Anleger gemäß Artikel 423-49 der Allgemeinen Vorschriften der AMF; oder ein ausländischer Anleger, der nach dem Recht seines Wohnsitzlandes einer vergleichbaren Kategorie angehört, in der Lage ist, mindestens 100.000 Euro zu investieren und eine langfristige Anlagelösung sucht.

Die Fonds von Altaroc Partners bergen Risiken in Bezug auf Kapitalverlust und Liquidität und sind möglicherweise nicht geeignet für Anleger, die planen, vor Ablauf der empfohlenen Anlagedauer auszusteigen.

Bevor Sie fortfahren, bitten wir Sie, die Informationen im Abschnitt „Rechtliche Hinweise“ sorgfältig zu lesen – zu Ihrem Schutz und in Ihrem eigenen Interesse.

Dieser Bereich der Website von Altaroc Partners ist ausschließlich privaten, nicht-professionellen Anlegern im Sinne der Richtlinie 2014/65/EU sowie ausländischen Investoren vorbehalten, die einer gleichwertigen Kategorie gemäß den Gesetzen ihres Wohnsitzlandes angehören. Bevor Sie die Website aufrufen, bitten wir Sie, die Informationen im Impressum („Rechtliche Hinweise“) sorgfältig und zu Ihrem eigenen Schutz aufmerksam zu lesen.

Indem ich fortfahre, bestätige ich, dass ich die Nutzungsbedingungen dieser Website gelesen habe und akzeptiere.

Questa sezione del sito web di Altaroc Partners è riservata esclusivamente agli investitori privati non professionali ai sensi della Direttiva 2014/65/UE e agli investitori esteri appartenenti a una categoria equivalente in base alla normativa del paese di appartenenza. Prima di consultare il sito, vi invitiamo a leggere attentamente le informazioni contenute nelle note legali, per la vostra protezione e nel vostro interesse.Procedendo, confermo di aver letto e di accettare le condizioni di utilizzo di questo sito.

Questa sezione del sito web di Altaroc Partners è riservata esclusivamente agli investitori professionali o esperti.

Accedendo, confermate di essere un investitore professionale ai sensi della Direttiva 2014/65/UE e dell’articolo L.533-16 del Codice Monetario e Finanziario francese, con l’esperienza, le conoscenze e le competenze necessarie per prendere decisioni d’investimento autonome e valutare correttamente i rischi connessi; un investitore esperto come definito dall’articolo 423-49 del Regolamento Generale dell’AMF; oppure un investitore estero appartenente a una categoria equivalente secondo la normativa del proprio Paese di residenza, in grado di investire un importo minimo di 100.000 euro e interessato a un investimento a lungo termine.I fondi di Altaroc Partners comportano rischi di perdita del capitale e di liquidità, e potrebbero non essere adatti a investitori che prevedono di disinvestire prima del periodo di detenzione raccomandato.

Prima di proseguire, vi invitiamo a leggere attentamente le informazioni contenute nella sezione “Note legali”, per la vostra tutela e nel vostro interesse.

Cette partie du site Internet d’Altaroc Partners est réservée aux Investisseurs privés non professionnels au sens de la directive 2014/65/UE ainsi qu’aux investisseurs étrangers appartenant à une catégorie équivalente sur le fondement du droit du pays dont ils relèvent. Avant de consulter le site, nous vous prions de lire attentivement les informations présentes dans les mentions légales pour votre protection et dans votre intérêt. J’ai lu et j’accepte les modalités d’utilisation de ce site dès lors que je me connecte.

Cette partie du site Internet d’Altaroc Partners est réservée aux Investisseurs privés non professionnels au sens de la directive 2014/65/UE ainsi qu’aux investisseurs étrangers appartenant à une catégorie équivalente sur le fondement du droit du pays dont ils relèvent. Avant de consulter le site, nous vous prions de lire attentivement les informations présentes dans les mentions légales pour votre protection et dans votre intérêt. J’ai lu et j’accepte les modalités d’utilisation de ce site dès lors que je me connecte.

Cette partie du site Internet d’Altaroc Partners est réservée aux seuls investisseurs professionnels ou avertis.

‍En y accédant, vous confirmez être un investisseur professionnel au sens de la directive 2014/65/UE et de l’article L.533-16 du Code monétaire et financier, disposant de l’expérience, des connaissances et des compétences nécessaires pour prendre vos propres décisions d’investissement et évaluer correctement les risques encourus ; un investisseur averti tel que défini à l’article 423-49 du Règlement général de l’AMF, ou un investisseur étranger appartenant à une catégorie équivalente en vertu du droit de votre pays de résidence, susceptible d’investir un montant minimum de 100.000 euros et recherchant un placement de long terme.

Les fonds d’Altaroc Partners comporte des risques de perte en capital et de liquidité et pourrait ne pas convenir aux investisseurs qui prévoient de retirer leur apport avant la durée de placement recommandée. Avant de consulter le site, nous vous prions de lire attentivement les informations présentes dans les « mentions légales » pour votre protection et dans votre intérêt.

Cette partie du site Internet d’Altaroc Partners est réservée aux seuls investisseurs professionnels ou avertis.

‍En y accédant, vous confirmez être un investisseur professionnel au sens de la directive 2014/65/UE et de l’article L.533-16 du Code monétaire et financier, disposant de l’expérience, des connaissances et des compétences nécessaires pour prendre vos propres décisions d’investissement et évaluer correctement les risques encourus ; un investisseur averti tel que défini à l’article 423-49 du Règlement général de l’AMF, ou un investisseur étranger appartenant à une catégorie équivalente en vertu du droit de votre pays de résidence, susceptible d’investir un montant minimum de 100.000 euros et recherchant un placement de long terme.

Les fonds d’Altaroc Partners comporte des risques de perte en capital et de liquidité et pourrait ne pas convenir aux investisseurs qui prévoient de retirer leur apport avant la durée de placement recommandée. Avant de consulter le site, nous vous prions de lire attentivement les informations présentes dans les « mentions légales » pour votre protection et dans votre intérêt.

This section of the Altaroc Partners website is exclusively intended for private investors who are classified as non-professional under Directive 2014/65/EU, as well as international investors belonging to an equivalent category pursuant to the applicable regulations of their country of residence. Before accessing the website, please carefully review the information provided in the Legal Notice section, which has been prepared for your protection and benefit. By proceeding, I confirm that I have read and accept the terms and conditions of use for this website.

This section of the Altaroc Partners website is exclusively reserved for professional or qualified investors.By accessing this content, you confirm that you are either:

  • A professional investor as defined by Directive 2014/65/EU (MiFID II) and Article L.533-16 of the French Monetary and Financial Code, possessing the necessary experience, knowledge, and expertise to make your own investment decisions and properly evaluate associated risks;
  • A qualified investor as defined in Article 423-49 of the AMF General Regulation; or
  • An international investor belonging to an equivalent category under the laws of your country of residence, able to invest a minimum amount of €100,000 and seeking a long-term investment.

Funds managed by Altaroc Partners involve risks, including capital loss and liquidity constraints, and may not be suitable for investors planning to withdraw their investment before the recommended holding period.Before proceeding, please carefully review the information provided in the "Legal Notice" section for your own protection and benefit

This section of the Altaroc Partners website is exclusively reserved for professional or qualified investors.By accessing this content, you confirm that you are either:

  • A professional investor as defined by Directive 2014/65/EU (MiFID II) and Article L.533-16 of the French Monetary and Financial Code, possessing the necessary experience, knowledge, and expertise to make your own investment decisions and properly evaluate associated risks;
  • A qualified investor as defined in Article 423-49 of the AMF General Regulation; or
  • An international investor belonging to an equivalent category under the laws of your country of residence, able to invest a minimum amount of €100,000 and seeking a long-term investment.

Funds managed by Altaroc Partners involve risks, including capital loss and liquidity constraints, and may not be suitable for investors planning to withdraw their investment before the recommended holding period.Before proceeding, please carefully review the information provided in the "Legal Notice" section for your own protection and benefit

This section of the Altaroc Partners website is exclusively intended for private investors who are classified as non-professional under Directive 2014/65/EU, as well as international investors belonging to an equivalent category pursuant to the applicable regulations of their country of residence. Before accessing the website, please carefully review the information provided in the Legal Notice section, which has been prepared for your protection and benefit. By proceeding, I confirm that I have read and accept the terms and conditions of use for this website.

This website allows you to consult only the information related to the Funds that are subject to a public offering in the selected country. This website is not intended for individuals subject to jurisdictions where the publication or access to the website is prohibited due to their nationality or place of residence. Individuals accessing the website acknowledge that they are solely responsible for complying with the laws and regulations applicable in their country of residence and/or nationality.

This website is an informational platform designed to present the portfolio management activities of Altaroc Partners S.A., as well as the main characteristics of its Funds and services. No information or opinion expressed on this website constitutes a solicitation, an offer, or a recommendation to buy, sell, or transfer an investment, to engage in any other transaction, or to provide investment advice or services.

Before investing in a Fund, which by nature involves a risk of loss of the invested capital, we invite you to consult an investment advisor and to review the Key Information Document (KID), the prospectus, and any other supplementary information available on this website. A paper version can be requested from any authorized distributor or directly from the Management Company. These documents will be provided free of charge at any time upon request.

Please note that the information and documents provided do not take into account your personal investment objectives, strategy, tax status, risk appetite, or investment horizon. We recommend consulting your personal advisor for tailored investment advice.

Altaroc Partners S.A. reserves the right to modify the content of this website at its sole discretion and without prior notice.

Investors are reminded that past performance is not indicative of future results and is not constant over time. Our Funds do not offer any guarantee of returns or performance and involve a risk of capital loss. Past performance should not be the primary factor in your investment decision.

This website is not intended for citizens or residents of the United States of America or “U.S. Persons” as defined under “Regulation S” of the United States Securities Act of 1933. None of the Funds presented herein may be offered or sold, directly or indirectly, in the United States of America, to residents or citizens of the United States of America, or to “U.S. Persons.”

By choosing to access our website, you acknowledge having read and accepted these Terms and confirm that you are accessing this website in compliance with the laws and regulations of the jurisdiction or country in which you reside.

‍

This website allows you to consult only the information related to the Funds that are subject to a public offering in the selected country. This website is not intended for individuals subject to jurisdictions where the publication or access to the website is prohibited due to their nationality or place of residence. Individuals accessing the website acknowledge that they are solely responsible for complying with the laws and regulations applicable in their country of residence and/or nationality.

This website is an informational platform designed to present the portfolio management activities of Altaroc Partners S.A., as well as the main characteristics of its Funds and services. No information or opinion expressed on this website constitutes a solicitation, an offer, or a recommendation to buy, sell, or transfer an investment, to engage in any other transaction, or to provide investment advice or services.

Before investing in a Fund, which by nature involves a risk of loss of the invested capital, we invite you to consult an investment advisor and to review the Key Information Document (KID), the prospectus, and any other supplementary information available on this website. A paper version can be requested from any authorized distributor or directly from the Management Company. These documents will be provided free of charge at any time upon request.

Please note that the information and documents provided do not take into account your personal investment objectives, strategy, tax status, risk appetite, or investment horizon. We recommend consulting your personal advisor for tailored investment advice.

Altaroc Partners S.A. reserves the right to modify the content of this website at its sole discretion and without prior notice.

Investors are reminded that past performance is not indicative of future results and is not constant over time. Our Funds do not offer any guarantee of returns or performance and involve a risk of capital loss. Past performance should not be the primary factor in your investment decision.

This website is not intended for citizens or residents of the United States of America or “U.S. Persons” as defined under “Regulation S” of the United States Securities Act of 1933. None of the Funds presented herein may be offered or sold, directly or indirectly, in the United States of America, to residents or citizens of the United States of America, or to “U.S. Persons.”

By choosing to access our website, you acknowledge having read and accepted these Terms and confirm that you are accessing this website in compliance with the laws and regulations of the jurisdiction or country in which you reside.

‍

Country
---
Language
---
Profile
---
Disclaimer
---
General Terms and Conditions
Previous
Scroll down to accept General Terms and Conditions
Accept
The webpage you are trying to access is not available in your country.
Back to homepage